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Abstract
Background: CRISPR/Cas is a widespread adaptive immune system in prokaryotes. This system integrates short stretches of
DNA derived from invading nucleic acids into genomic CRISPR loci, which function as memory of previously encountered
invaders. In Escherichia coli, transcripts of these loci are cleaved into small RNAs and utilized by the Cascade complex to bind
invader DNA, which is then likely degraded by Cas3 during CRISPR interference.
Results: We describe how a CRISPR-activated E. coli K12 is cured from a high copy number plasmid under non-selective
conditions in a CRISPR-mediated way. Cured clones integrated at least one up to five anti-plasmid spacers in genomic
CRISPR loci. New spacers are integrated directly downstream of the leader sequence. The spacers are non-randomly selected
to target protospacers with an AAG protospacer adjacent motif, which is located directly upstream of the protospacer. A co-
occurrence of PAM deviations and CRISPR repeat mutations was observed, indicating that one nucleotide from the PAM is
incorporated as the last nucleotide of the repeat during integration of a new spacer. When multiple spacers were integrated
in a single clone, all spacer targeted the same strand of the plasmid, implying that CRISPR interference caused by the first
integrated spacer directs subsequent spacer acquisition events in a strand specific manner.
Conclusions: The E. coli Type I-E CRISPR/Cas system provides resistance against bacteriophage infection, but also enables
removal of residing plasmids. We established that there is a positive feedback loop between active spacers in a cluster – in
our case the first acquired spacer - and spacers acquired thereafter, possibly through the use of specific DNA degradation
products of the CRISPR interference machinery by the CRISPR adaptation machinery. This loop enables a rapid expansion of
the spacer repertoire against an actively present DNA element that is already targeted, amplifying the CRISPR interference
effect.
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Introduction
Prokaryotes have evolved an adaptive immune system called
CRISPR/Cas (clustered regularly interspaced short palindromic
repeats and CRISPR associated protein) that enables them to
counter invasions from viruses and plasmids (reviewed by
[1,2,3,4]). This immune system contains genomic CRISPR loci
in which genetic material from invaders is incorporated.
Memorized invaders can be recognized by expressing incorporat-
ed genetic material as small RNA molecules, which can guide Cas
protein complexes to invader nucleic acid sequences.
The E. coli K12 genome encodes only a Type I-E CRISPR/Cas
system [5,6]. This system is capable of providing resistance to
bacteriophage infection, prophage induction and plasmid trans-
formation [7,8,9]. Comparative genomics has shown that the E.
coli K12 genome contains two CRISPR loci with type 2 repeats
and a variable spacer content (CRISPR locus 2.1 (12 spacers) and
2.3 (6 spacers)), suggesting that both loci are active [5,10].
CRISPR locus 2.1 is located directly downstream of a Cas gene
operon, while locus 2.3 does not have any cas genes encoded in its
proximity. Both CRISPR loci have a conserved AT-rich leader
sequence that acts as a promoter [11] and consist of 29 nucleotide
palindromic repeats that are separated from each other by 32 or
33 nucleotide guide sequences called spacers. CRISPR transcripts
are cleaved into mature CRISPR RNAs (crRNA) and these
remain bound by the ribonucleoprotein complex Cascade (Cas-
complex for antiviral defence, in Type I-E consisting of proteins
encoded by cas genes cse1, cse2, cas7, cas5 and cas6e) to guide the
interference machinery to target DNA sequences (i.e. protospacers)
[12]. In addition to Cascade, resistance requires the nuclease and
helicase Cas3 [7,13,14]. Cas3 is recruited to the target DNA by the
Cascade protein Cse1, after which Cas3 nicks the target DNA and
further degrades the target DNA by ATP-dependent helicase and
ssDNA nuclease activities [15].
Transcription of the Type I-E Cascade-cas1-cas2 operon, and to
some extent the CRISPR array, is repressed in this strain by the
global transcriptional repressor H-NS (heat-stable nucleoid-
structuring protein [11,16,17]. In the hns knock-out strain of E.
coli K12 repression of the Cas genes is at least partially relieved
[17], resulting in an activated CRISPR/Cas phenotype. Although
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the expression and interference stages of CRISPR immunity have
been studied in E. coli, the process of acquiring spacers to modify
the viral and plasmid specificity of the immune system has not yet
been described.
The Streptococcus thermophilus Type II system integrates new
spacers against bacteriophages [1,18] and plasmids [19], and
thereby acquires resistance to these bacteriophages (BIM:
bacteriophage insensitive mutant) or cures itself from the
corresponding plasmids (PIM: plasmid interfering mutant). The
Type II specific Cas protein Csn2 [6], a calcium-dependent
dsDNA binding protein [20], was reported to be essential during
the spacer integration process in S. thermophilus [1]. In E. coli, Cas1
and Cas2 are not required during CRISPR expression or
interference [7]. Their strict conservation with CRISPR loci
suggests involvement in CRISPR adaptation [21].
Here we describe that E. coli K12 Dhns is cured from a high copy
number plasmid by integrating new spacers into two CRISPR loci.
Based on our observations we propose that active spacers in a
cluster are used to expand the range of new spacers against the
same target in a strand specific manner.
Results and Discussion
Spacer Integration Results in Plasmid Curing and Plasmid
Interference
Upon prolonged cultivation (,1–2 weeks) at 37uC under non-
selective conditions E. coli Dhns is cured from the 3.7 kb high copy
number plasmid pRSF-1b. Out of 75 individual non-selectively
propagated clones tested, 59 (79%) were kanamycin sensitive and
16 (21%) kanamycin resistant. Sequencing of PCR amplicons of
CRISPR loci 2.1 and 2.3 showed that between one and five anti-
plasmid spacers were integrated in all KanS clones (Fig. 1, Table
S1), while KanR clones did not contain any new spacers. No
plasmid DNA could be isolated from eight out of eight tested KanS
clones (nr. 1, 2, 3, 4, 6, 7, 19, and 27; Fig. 1, Table S1), confirming
that the KanS clones were indeed cured from pRSF-1b. When
these clones were retransformed with pRSF-1b a 100- to 1000-fold
drop in transformation efficiency was observed for clones with one
or two integrated spacers, respectively (Fig. 2). These combined
results indicate that the KanS clones are indeed PIMs. When
retransformation efficiencies of PIMs with spacers integrated in
either CRISPR 2.1 or 2.3 were compared, no significant
differences in efficiencies could be observed, indicating that
spacers from both loci are actively transcribed and utilized.
Transformation of the PIMs with the target plasmid is not
completely inhibited because point mutations in the protospacer at
critical positions (seed region or protospacer adjacent motif (PAM)
[22]), or deletions, allow pRSF-1b to ‘escape’ the CRISPR
interference [9]. This explains why PIMs containing multiple anti-
plasmid spacers exhibited lower transformation efficiencies as
mutation of multiple protospacers or their PAMs simultaneously
occurs at lower frequencies.
Sequencing of the leader-flanking end of CRISPR loci 2.1 and
2.3 of a random selection of 46 KanS clones revealed a total of 27
unique PIMs carrying a total of 37 different anti-plasmid spacers
(Fig. 1, Table S1). While 13 PIMs had integrated a single new
spacer, 7, 4, 2 and 1 PIMs integrated two, three, four and five new
spacers, respectively. Of all different PIMs, 67% had integrated
between one and three spacers in the CRISPR 2.1 locus, while
74% had integrated one or two spacers into the CRISPR 2.3
locus, indicating that both clusters are active.
New spacers were always integrated directly downstream from
the leader-flanking repeat. This suggests that there is a specific
signal in the leader sequence to integrate new repeat-spacer units
at this position in the CRISPR array. No spacer deletion was
observed, indicating that the acquisition of new spacers occurs via
addition rather than substitution. This is in agreement with
findings in S. thermophilus, where repeat-spacer units were also
mainly added directly downstream of the leader sequence
[1,18,19]. In agreement with our findings, bioinformatic analyses
have shown that spacer turnover and internal spacer integration is
a rare event in E. coli [5,23].
AAG is the Dominant Protospacer Adjacent Motif
The protospacer adjacent motif (PAM) is a short conserved
nucleotide sequence located in a protospacer flanking region [22].
The analysis of spacer-protospacer pairs from over 150 species has
revealed the existence of several PAM consensus sequences which
co-occur with specific repeat types [22]. The PAM consensus
sequence 59-AWG-protospacer-39 was identified for E. coli [22].
When present, PAMs are essential for CRISPR-interference as a
point mutation in the PAM allows bacteriophages to escape the
immune system [9,24]. For E. coli it was shown that mutations in
the PAM result in dramatically lower target DNA binding affinity
of the crRNA guided complex Cascade [9], explaining how the
bacteriophage genome can avoid being detected.
Of all integrated spacers, 29 (78%) corresponded to proto-
spacers with an AAG PAM, one (3%) with an ATG PAM, and
seven (19%) with non-consensus PAM sequences (AAA, AGG (2x),
GAG, TAG, CGA, AAT; Table S1). Although the functionality of
only the ATG PAM has been verified in E. coli [9], the majority of
integrated spacers in our experiments correspond to protospacers
flanking an AAG PAM. It could be argued that spacers are
selected randomly followed by natural selection. Clones that have
integrated spacers with a consensus PAM (AWG) are cured from
the high copy number plasmid pRSF-1b and generally gain an
energetic growth advantage [25], which allows them to outgrow
clones that have incorporated spacers with non-functional PAMs.
However, this would have resulted in a more equal distribution of
AAG and ATG PAMs, making the random spacer selection
process unlikely. Furthermore, since an AAG triplets are found less
frequently on pRSF-1b than ATG triplets (94 times AAG versus
129 times ATG), limited availability ATG is not the reason for
AAG PAM selection. Moreover, five spacers were integrated
multiple times in unrelated PIMs and in different CRISPR loci (S4
in PIM 20 (26) and 25; S8 in PIM 5, 9, 17 and 25; S12 in PIM 10,
11 and 18; S33 in PIM 14 and 23; S34 in PIM 17, 22 and 25)
which also argues against random spacer selection. These findings
indicate that there is a selection for AAG PAM sequences during
spacer acquisition.
It is worth noting that three PIMs (4, 19, and 27) integrated a
single anti-plasmid spacer corresponding to the non-PAM
consensus sequences AGG, GAG and AAT. Sequencing of
pRSF-1b in the corresponding regions excluded the possibility
that the plasmid contained mutations at these positions, confirm-
ing that these PAMs were indeed non-consensus PAM sequences.
The fact that these PIMs were cured from the plasmid, and were
less susceptible to retransformation of the target plasmid (Fig. 2)
indicates that these non-consensus PAMs are additionally allowed
during CRISPR interference. PIM 1, which integrated a spacer
with a non-consensus AAA PAM and one other spacer, shows
resistance typical for PIMs with two functional spacers. This
indicates that also this PAM is likely to be allowed during CRISPR
interference.
Interestingly, the AAT-PAM spacer S16 in PIM 27 which
targets the kanamycin resistance gene provides higher resistance to
retransformation with the target plasmid than single spacers in
PIM 4 and 19 targeting the same gene (Fig. 2). This can be
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explained by the fact that this spacer targets a relatively well
conserved region of the kanamycin resistance gene encoding
Glu68 [26,27]. Mutation of the S16 protospacer may therefore
result in more frequent loss of Kanamycin nucleotidyl transferase
activity.
Counterselection for Self-targeting Spacers
The locations of the protospacers were mapped on both strands
of the plasmid (43% and 57% on the (+) and (2) strand,
respectively) and covered regions of the backbone and multiple
cloning site (32%), origin of replication (40%) and the kanamycin
Figure 1. Graphical representation of spacers integrated in the various PIMs. Both CRISPR locus 2.1 and 2.3 of each PIM are displayed. The
newly acquired spacer positions (23, 22, 21) and original spacer positions (1, 2, 3) correspond to the order of spacers downstream from the leader
sequence (displayed as black triangle). White and red spacer boxes indicate that the corresponding protospacer is located on the – or + strand of the
plasmid, respectively. PIMs clustered in grey boxes possibly share a common ancestor. Spacers have an AAG PAM unless indicated otherwise.
Additional information on spacers is given in Table S1.
doi:10.1371/journal.pone.0035888.g001
Figure 2. Effect of integrated spacers on retransformation efficiency. Transformation efficiencies of various PIMs and the control (Wild type
E. coli K12 W3110) are given in a logarithmic scale as colony forming units (CFU) per mg of pRSF-1b plasmid DNA. For each PIM, the number of spacers
integrated in either CRISPR locus 2.1 or 2.3 is given. All spacers have an AAG PAM, unless indicated otherwise. The exact spacer composition of each
PIM is given in Table S1.
doi:10.1371/journal.pone.0035888.g002
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resistance gene (24%) (Fig.3). This indicates that protospacer
acquisition occurs independently of transcription or direction of
replication of the plasmid. Interestingly, only a single spacer (2%)
was integrated against the plasmid-encoded lacI gene (S36; Fig. 3).
This observation can be explained by the presence of a nearly
identical copy (one nucleotide difference) of the lacI gene in the E.
coli K12 genome. Spacers targeting the plasmid encoded lacI gene
would therefore also target the E. coli genome, leading to lethal
DNA damage, and resulting in a counterselection for these
variants. This result fits very well with the observation that spacers
against a prophage are lethal to E. coli [8]. The identified anti-lacI
spacer in PIM 23 has a non-consensus PAM CGA that possibly
prevents self-targeting. The plasmid interfering phenotype of this
PIM is likely to be caused by the two additional spacers
corresponding to protospacers with AAG PAMs (Fig. 1, Table S1).
Nucleotide Composition of Spacers
The nucleotide content of the 37 unique anti-plasmid spacers
was compared with the composition of all possible AAG-flanking
protospacers on pRSF-1b (Fig. 4). The analysis showed that the
integrated spacers displayed no selection bias for GC-content. This
suggests that GC content of the protospacers, and therefore the
local stability of the DNA duplex, plays no major role during
spacer selection. In addition to GC content, we also analysed
purine (AG) content of the new spacers (Fig. 4), as purine-rich
RNA is known to basepair energetically more favourable with
DNA than the corresponding DNA:DNA duplex [28,29]. This
may be of importance during the hybridization of the crRNA to
double stranded target DNA molecules. Again, no apparent bias
could be observed compared to the semi-randomly generated
spacer set, suggesting that the energetic gain of pairing purine rich
crRNA with DNA by Cascade is not taken into account by the
CRISPR adaptation machinery during spacer integration. Also no
bias was found for GC or AG-content in the seed sequence, which
plays an important role in during target DNA binding of Cascade
[9].
The Last Nucleotide of the Repeat is PAM Derived
It has previously been described that repeats of CRISPR 2.1
and 2.3 (consensus: 59-GWGTTCCCCGCGCCAGCGGGGA-
TAAACCG-39) contain polymorphisms [5]. Some polymorphisms
in the repeats have been associated with preventing self-targeting,
as self-targeting spacers are often accompanied by degraded
repeats [30]. Especially the last 8 nucleotides of the repeat, which
determine the first 8 nucleotides of mature crRNAs, appear to be
important for the functioning of CRISPR/Cas systems [4]. The
Type III-a system of Staphylococcus epidermidis uses differential
complementarity of these first 8 nucleotides of the crRNA with one
protospacer flank to discriminate between self DNA (the CRISPR)
and non-self DNA (the target), preventing autoimmunity [31].
Other CRISPR/Cas systems may use PAMs to determine if a
sequence will be targeted [9,18,19,22].
Our dataset shows that the last three nucleotides of the repeat
(CCG) occasionally carry mutations. Repeat 2 of CRISPR locus
2.3 in the parental strain contains a polymorphism at the last
nucleotide, changing the trinucleotide sequence from CCG to
Figure 3. Linear display of pRSF-1b and locations of protospacers. The (+) and (2) strands and corresponding protospacers are coloured red
and black, respectively. Kanamycin marker (Kan), Origin of replication (Ori) and lacI (LacI) are shown as arrows. Protospacers have an AAG PAM unless
indicated otherwise.
doi:10.1371/journal.pone.0035888.g003
Figure 4. Graphical representation of AG and GC contents of
each observed and possible spacer. Observed spacers (X) are
spacers integrated in CRISPR loci 2.1 and 2.3 (Table S1). These spacers
are 32 or 33-mers with various PAMs. Possible spacers (O) are all 32-
mers found on pRSF-1b directly downstream of an AAG PAM.
doi:10.1371/journal.pone.0035888.g004
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CCT. Almost all PIMs with new spacers in CRISPR 2.3, however,
did not carry this polymorphism in their new repeats, indicating
that the second repeat in a CRISPR is not duplicated during the
spacer integration process.
S16 is preceded by a CCT trinucleotide repeat sequence, and
strikingly this spacer corresponds to a protospacer with non-
consensus AAT PAM. This combination is apparently functional,
as this PIM is cured from the plasmid and is less susceptible for
retransformation with pRSF-1b (Fig. 2), while carrying only one
anti-plasmid spacer. This indicates that S16 facilitates interference
although it has a non-consensus PAM and a mutated repeat.
S31 in PIM 1 is preceded by aCCA trinucleotide repeat sequence
andithas thenon-consensusAAAPAM,whilespacerS36inPIM23is
preceded by repeat sequence CCA and targets a plasmid sequence
flanking a non-consensus CGA PAM. Because PIM 1 and 23 each
contain additional typical anti-plasmid spacers, it cannot be
concluded whether S31 and S23 are functional. However PIM 1
(carrying S31 and typical spacer S17) shows a decrease in
transformation efficiency similar to PIMs with two typical anti-
plasmid spacers (Fig. 2), suggesting that S17 is indeed functional.
Interestingly, the last nucleotide of the repeat preceding the new
spacer always matched the third nucleotide of the PAM, both in
normal situations (repeat CCG, andAAG,match underlined) and in
deviations from normal (CCTR – AATP; CCAR – CGAP; CCAR –
AAAP;Fig.5A).The singlenucleotidepolymorphism(SNP)at the last
position of the repeat and corresponding deviations from the PAM
consensus sequence suggests that the last nucleotide of the repeat is
derived from the PAM in the target DNA (Fig. 5B). Evidence
supporting thishypothesis isprovided inPIMs1and23whichcontain
thedeviated repeat-spacer unit at the secondposition in the locus and
have a consensus repeat-spacer unit at the first position. Apparently,
the repeat SNP is not propagated in the new repeat-spacer unit at the
firstposition in the locus (TableS1,PIM1andPIM23),but reverted to
the repeat-consensus by the selection of a normal AAG PAM-
containing protospacer. We hypothesize that the protospacer-
flanking nucleotide of the PAM is still attached to the selected, to-
be-integrated spacer (pre-spacer [32]), and forms the last nucleotide
of the proximal repeat after integration is complete (Fig. 5B). As a
consequence, this nucleotide in the crRNA is always complementary
to the protospacer-flanking nucleotide of the PAM (Fig. 5C), even
when a non-consensus PAM is selected during spacer acquisition.
Spacer Integration Patterns Suggest a Positive Feedback
Loop of Active Spacers
In 14 different PIMs, two or more spacers were integrated (Fig. 1,
TableS1).Nopreference for a specific target locationof subsequently
integrated spacerscouldbedetected, suchasa locationnear the target
site of the primary integrated spacer. However, all spacers of an
individual PIM always targeted the same strand of the plasmid,
implying that the primary integrated spacer determineswhich strand
subsequently integrated spacers will target. This suggests a positive
feedback loop that may result from interplay between the CRISPR
interference machinery (Cascade and Cas3) and the spacer
integration machinery. We hypothesize that CRISPR-mediated
plasmid degradation by Cas3 [15], guided by crRNA from an active
spacer – the first new spacer in this case - generates specific DNA
degradation products that are used as precursors for subsequent new
spacers (Fig. 6). These findings are in contrast with new spacer
integration patterns in S. thermophilus, where secondary spacers show
no strand selection bias [1,18,33] suggesting that CRISPR
Figure 5. PAM and repeat-end correlation. (A): PAMs of observed spacers and the co-occurring trinucleotide repeat-ends associated with these
spacers. Notice that the spacer-proximal nucleotide of the repeat end is identical to the protospacer-proximal nucleotide of the PAM. (B): Schematic
of the proposed mechanism for spacer acquisition during CRISPR adaptation. A protospacer with specific PAM is selected after which it is processed
into the pre-spacer (at least 33–34 bp), which contains the last nucleotide of the PAM (the pre-spacer could be single-stranded or double-stranded).
The pre-spacer is than integrated at the leader proximal end of the CRISPR locus. The nucleotide derived from the PAM forms the last nucleotide of
the repeat. (C): R-loop formation by mature crRNA (61 nucleotides) during CRISPR interference. Notice that the last nucleotide of the repeat (the
nucleotide derived from the PAM) is complementary to the target DNA sequence. It remains unknown whether base-pairing between these
nucleotides is important for interference.
doi:10.1371/journal.pone.0035888.g005
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acquisition andCRISPR interference by Cas9 [34] are independent
processes in S. thermophilus.
Conclusions
E. coli K12 is cured from a high copy number plasmid by
integrating anti-plasmid spacers in two of its CRISPR loci. New
spacers are selected in a non-random process that takes into
account the presence of a PAM on the target DNA. We
hypothesize that the mechanism of CRISPR adaptation in Type
I-E systems involves selection of protospacers including one
nucleotide from the PAM, which determines the last nucleotide
of the preceding repeat. Spacer analysis further suggests a positive
feedback loop between active spacers in a cluster and newly
acquired spacers, through interplay of the CRISPR interference
and adaptation machinery. Possibly the target DNA degradation
products generated by Cascade and Cas3 serve as precursors for
the integration of new spacers against the same target (Fig. 6).
Increasing the number of spacers targeting an invading DNA
element may represent an efficient strategy to expand the
repertoire of spacers targeting a specific invader to amplify the
CRISPR interference effect. Having multiple active spacers
against the same target reduces the chance that invaders evade
immunity by point mutation in the seed region of the protospacer
or PAM, since point mutations at multiple target sites simulta-
neously occur at lower frequencies.
Materials and Methods
Plasmid Curing
Escherichia coli K12 W3110 derivate Dhns (JW1225) from the
KEIO collection [35] was supplied by the American Type Culture
Collection (ATCC). Its kanamycin resistance marker was removed
according to protocol described by Datsenko et al [36]. This strain
was transformed with high copy number plasmid pRSF-1b
(Novagen) (RSF1030 origin of replication, .100 copies/cell,
3.7 kb [37]) as described below. Colonies were picked from an LB-
agar plate containing 100 mg/mL kanamycin and used to
inoculate 2YTL medium [7] containing no antibiotics. The
culture was transferred daily to fresh 2YTL medium in a shaking
incubator for prolonged periods of time (,1–2 weeks). The culture
was regularly checked for plasmid loss by plating on non-selective
LB-plates, followed by replica streaking on selective and non-
selective plates.
Transformations
Cells for the plasmid curing experiments and retransformation
experiments were made chemically competent using the RuCl
method and transformed by applying a heat-shock as described in
the QIAexpressionist handbook (QIAGEN). After transformation,
cells were plated on an LB-agar plate containing 100 mg/mL
kanamycin.
Colony PCR
Clones were screened for spacer integration by colony PCR
using DreamTaq Green DNA polymerase (Fermentas). New
spacers in the CRISPR 2.1 locus were PCR amplified using
forward primer BG3474 (95-AAATGTTACAT-
TAAGGTTGGTG-93) annealing 72 bases upstream of the first
repeat and reverse primer BG3475 (95-GAAATTCCAGACCC-
GATCC-93) annealing in spacer 4 of this locus. New spacers in the
CRISPR 2.3 locus were PCR amplified using forward primer
BG3414 (95-GGTAGATTTTAGTTTGTATAGAG-93) anneal-
ing 164 bases upstream of the first repeat and BG3415 (95-
CAACAGCAGCACCCATGAC-93) annealing in spacer 3 of this
locus. PCR product sizes were estimated using agarose gels and
SYBR-safe DNA gel stain (Invitrogen). The CRISPR 2.1 and 2.3
loci of 46 clones KanS clones were sequenced by GATC-Biotech
(Konstanz, Germany) with BG3474 and BG3414, respectively.
Spacer Composition Analysis
Nucleotide analyses were carried out using in-house perl scripts.
In brief, all 32-mers from plasmid pRSF-1b preceded by the PAM
AAG were tested for their nucleotide composition, and compared
Figure 6. Model of the strand specific positive feedback loop. Cells with a spacer against a known and actively present invader DNA produce
targeting Cascade complexes in the expression stage. In the interference stage, Cascade binds the target dsDNA after which the target is cleaved and
degraded by Cas3 [15]. DNA degradation products generated by Cascade and Cas3 (which could be ssDNA or dsDNA) act as precursors for new
spacers in the adaptation phase in a strand-specific manner. By integration of these strand-specific precursors, the spacer repertoire against an
actively present invader is expanded, completing the positive feedback loop.
doi:10.1371/journal.pone.0035888.g006
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to the nucleotide composition of all experimentally retrieved
spacers.
Plasmid Loss Studies
PIM 1, 2, 3, 4, 6, 7, 19 and 27 were cultured in 5 ml LB
medium without antibiotics, and were incubated o/n in a rotary
shaker at 37uC. The o/n cultures were miniprepped (GeneJET,
Fermentas) and the absence of plasmid DNA in the eluate was
verified by nanodrop and agarose gel electrophoresis. The same
PIMs and the wild-type control strain were retransformed with
pRSF-1b and plated on LB-agar plates containing 50 mg/ml Kan.
Transformations efficiency was determined as the number of
colony forming units per mg plasmid DNA.
Supporting Information
Table S1 Integrated spacer sequences. PIM: Plasmid interfering
mutant, Spacer#: spacer number, corresponds to spacer locations
in Fig. 1 and Fig. 3. PAM: protospacer adjacent motif, non-
consensus PAMs are underlined. Target: Location of protospacer
on pRSF-1b (Kan: Kanamycin resistance gene. Ori: RSF1030
origin of replication. Bb: pRSF-1b backbone, lacI: lac operon
repressor gene). Target position: Nucleotide position of the spacer
match (protospacer) on pRSF-1b. Spacers matching protospacers
on the (+) and (-) strand are coloured red and black, respectively.
Note that the actual targeted strand during CRISPR interference
by Cascade is the complementary strand of what is indicated here.
(DOCX)
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